Artificial Intelligence-Enabled Electrocardiogram Screening for Detection of Low Ejection Fraction in Routine Care: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Ann Noninvasive ElectrocardiolOct 30, 2026
Clinical ResearchCardiology

Ali Abdelhaleem Omar Ahmed, Omer Abdalhaleem Omer Ahmed, Rana Abdelhaleem Omar Ahmed et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated randomised controlled trials of AI-enabled ECG screening for low ejection fraction in adults without known heart failure undergoing routine ECGs. Three trials, including 37,467 participants, compared screening with usual care. After adjustment for clustering, AI-ECG screening increased detection of new low EF (≤ 50%) confirmed by echocardiography (RR 1.36, 95% CI 1.12 to 1.64; p = 0.002), with a number needed to screen of 204. Echocardiography referral rates did not differ significantly between groups.

Key findings

  • AI-ECG screening increased new low EF detection versus usual care (RR 1.36, 95% CI 1.12 to 1.64; p = 0.002; I 2 = 0%).
  • The number needed to screen to detect one additional case was 204.
  • Echocardiography referral rates were similar (RR 1.02, 95% CI 0.96 to 1.09; p = 0.55; I 2 = 36%).
  • Across studies, the AI tool’s positive predictive value ranged from approximately 20% to 34%.

Why it matters

Low ejection fraction may be present before heart failure is recognised, while symptoms can be non-specific. These trial findings suggest that AI analysis of routine ECGs can improve detection without a substantial increase in echocardiography referrals. The modest positive predictive values also underscore that screening results require clinical confirmation rather than being treated as diagnoses.

What to keep in mind

Only three RCTs were included, and the positive predictive value varied across studies. The authors note that validation across diverse AI platforms is still warranted.

Source

Published in Ann Noninvasive Electrocardiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.